Editorial for: “Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole‐body Diffusion‐weighted MR Imaging”
Journal of Magnetic Resonance Imaging · 2024
DOI: 10.1002/jmri.29158 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Magnetic Resonance Imaging, 2024. Verfasst von Sebastien Boutry und 2 weiteren Autor:innen. Beteiligte Einrichtung: Unit of General, Organic and Biomedical Chemistry, University of Mons (UMONS), Mons, Belgium. Hauptthemen laut MEDLINE: Multiple Myeloma, Diffusion Magnetic Resonance Imaging, Whole Body Imaging. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Analysis of tumor heterogeneity on medical images (MRI, PET, and CT) using descriptive parameters of histograms (mean, median, kurtosis, skewness, percentiles, etc.) was often performed aiming to characterize tumor malignity or monitor treatment response.1-3 MRI approaches such as dynamic contrast-enhanced and diffusion-weighted imaging (DWI) generate ranges of parametric data that can be distributed in histograms according to their frequencies of observation. In the present issue of JMRI, authors found a sensitive parameter among histogram metrics obtained from whole-body bone marrow (WBBM) DWI data to characterize treatment response of multiple myeloma patients.4 In MRI, the persistence of the (weak) MR signal coming from RF-pulsed water protons depends on the static magnetic field homogeneity. Magnetic field gradients, as a source of inhomogeneity, are thus basically responsible for “signal extinction” by dephasing it. Their application in two steps in the slice and frequency directions of the spatial encoding process allows for rephasing the signal that was dephased at first step. In standard DW MRI, two such successive magnetic field gradients (called diffusion gradients or b (sec/mm2)) are added in any of the three directions of spatial encoding. If the Brownian motion of water molecules is somehow impeded on the direction of the diffusion gradient application, their protons are allowed to better undergo the second (rephasing) gradient. The signal collected in DWI experiments thus depends on extracellular water content of tissues and how impeded its motion is (e.g., by cell density or macromolecules). Collecting DW images at growing strength of b (e.g., 3 b values) allows for measuring how the signal intensity of each pixel of the image varied along with the b values (higher b strengths having more impact on motion-related signal extinction). Processing of those three images gives access to a parameter called “apparent diffusion coefficient” (ADC value, in mm2/sec), that is featured by each pixel of an ADC map, on which gray levels represent how water diffusion takes place on the b direction, ranging from more impeded (dark pixel-low ADC) to “free” (bright pixel-high ADC) diffusion.5 In an article published in the present issue of JMRI, a retrospective study was performed in patients who were treated for multiple myeloma.4 According to specific response criteria established by the International Myeloma Working Group (IMWG), 30 of 36 patients were determined as “very good partial responders (or better)” to the treatment (VGPR+), and six were assigned as “less than very good partial responders” to the treatment (less than VGPR). As certain difficulties are met when estimating treatment response using clinical measurements (e.g., in plasma, urine), MRI assessment of bone marrow tumor involvement was included in those IMWG-defined diagnosis criteria.6-8 Thus, all patients underwent MRI and particularly WBBM-DWI before (baseline) and after treatment, allowing for calculation of total tumor volume ADC values (ttADC) from a semiautomatically contoured region corresponding to total tumor load of bone marrow. How easily water molecules diffuse in extracellular media can indeed be reflected by DW MRI and will give information about tumor cellularity or cell density (relevant for characterizing tumor invasion as tumor cell growth leaves only little interstitial space, restricting water motion), loss of cell integrity (relevant in the assessment of cell death (e.g., in anti-tumor therapy)), and, more specific to bone marrow, contents in yellow (fat with poor cellularity and water content) and red (higher cellularity and water content) bone marrow.6, 7 Several parameters, derived from the processing of histograms representing the distribution of ADC value ranges (intervals) as number of observations (frequency), were compared aiming to identify one or more (among a dozen of histogram metrics) that may significantly discriminate between the two groups of responders, before and after treatment. ADC change in the low percentile range ttADC_5% of histogram, representing post-treatment ttADC data, was found to be indicative of treatment response with highest sensitivity, potentially reflecting the reconversion of tumor-infiltrated bone marrow to yellow marrow, as it was indeed reported that VGPR+ patients showed a significantly higher increase in relative bone marrow fat fraction.9 Processing of pre- and post-treatment ttADC_5% percentiles by subtraction, gave a ΔttADC_5% value that also showed good significance in discriminating “VGPR+” from “less than VGPR” patients, and that will be further investigated. Despite a few limitations (i.e., inherent variability of chemotherapy cycles among retrospectively collected data, possible new lesions missed due to same segmented region kept on bone marrow ADC maps before and after treatment), this study reports an interesting and promising predictive indicator of multiple myeloma treatment response by clever use of histogram metrics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Unit of General, Organic and Biomedical Chemistry, University of Mons (UMONS), Mons, Belgium.
- Center for Microscopy and Molecular Imaging, Charleroi, Belgium.
ORCID-Profile: Sebastien Boutry, Sophie Laurent, Carmen Burtea
Zitieren
APA
Boutry, S., Laurent, S., & Burtea, C. (2024). Editorial for: “Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole‐body Diffusion‐weighted MR Imaging”. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29158
Vancouver
Boutry S, Laurent S, Burtea C. Editorial for: “Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole‐body Diffusion‐weighted MR Imaging”. Journal of Magnetic Resonance Imaging. 2024. doi:10.1002/jmri.29158
BibTeX
@article{Boutry2024,
author = {Boutry, Sebastien and Laurent, Sophie and Burtea, Carmen},
title = {Editorial for: “Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole‐body Diffusion‐weighted MR Imaging”},
journal = {Journal of Magnetic Resonance Imaging},
year = {2024},
doi = {10.1002/jmri.29158}
}
EUVIMED